CA2946676A1 - Method for the surface treatment of a biocorrodable implant - Google Patents

Method for the surface treatment of a biocorrodable implant Download PDF

Info

Publication number
CA2946676A1
CA2946676A1 CA2946676A CA2946676A CA2946676A1 CA 2946676 A1 CA2946676 A1 CA 2946676A1 CA 2946676 A CA2946676 A CA 2946676A CA 2946676 A CA2946676 A CA 2946676A CA 2946676 A1 CA2946676 A1 CA 2946676A1
Authority
CA
Canada
Prior art keywords
implant
weight
polarization
corrosion
biocorrodable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2946676A
Other languages
French (fr)
Inventor
Volkmar Neubert
Volkmar-Dirk Neubert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntellix AG
Original Assignee
Syntellix AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntellix AG filed Critical Syntellix AG
Publication of CA2946676A1 publication Critical patent/CA2946676A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/84Fasteners therefor or fasteners being internal fixation devices
    • A61B17/86Pins or screws or threaded wires; nuts therefor
    • A61B17/866Material or manufacture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/047Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/082Inorganic materials
    • A61L31/088Other specific inorganic materials not covered by A61L31/084 or A61L31/086
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C23/00Alloys based on magnesium
    • C22C23/06Alloys based on magnesium with a rare earth metal as the next major constituent
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D21/00Processes for servicing or operating cells for electrolytic coating
    • C25D21/12Process control or regulation
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D5/00Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
    • C25D5/18Electroplating using modulated, pulsed or reversing current
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D9/00Electrolytic coating other than with metals
    • C25D9/04Electrolytic coating other than with metals with inorganic materials
    • C25D9/08Electrolytic coating other than with metals with inorganic materials by cathodic processes
    • C25D9/12Electrolytic coating other than with metals with inorganic materials by cathodic processes on light metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/12Materials or treatment for tissue regeneration for dental implants or prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction

Abstract

The subject of the present invention is a method for the surface treatment of a biocorrodable implant by means of electrochemical reactions, comprising the steps of: a) providing an implant of a biocorrodable magnesium alloy; b) introducing the implant into an electrolyte with a pH of 9-13; c) electrochemically treating the surface of the implant, wherein the implant serves as the working electrode and there is also a counterelectrode, and wherein the working electrode is alternately polarized cathodically and anodically, the current density being set to -0.1 to -7 mA/cm2 for the cathodic polarization and to 0.1 to 2 mA/cm2 for the anodic polarization. A corresponding implant is also the subject of the invention.

Description

Method for the surface treatment of a biocorrodable implant The present invention relates to a method for the surface treatment of a biocorrodable implant by means of alternating cathodic and anodic polarization, and also to a corresponding implant.
The purpose of implants is to support or to replace body functions and the most varied embodiments of implants have been used in medical technology. In addition to implants for securing tissues, endovascular implants, dental prosthesis implants, joint replacement implants, implants are also used for the treatment of bone damage, such as screws, nails, plates, or as bone replacements.
Nowadays implants which are applied to the bone are generally manufactured from titanium.
In spite of the relatively good biocompatibility of titanium implants by comparison with other permanent implants, efforts have been made to further improve these titanium implants.
Coatings are often provided on the surface of the implant in order to improve the biocompatibility.
One disadvantage of the application of layers to the surface of the implant is a change to the geometry of the implant, even in the event of small layer thicknesses.
Moreover, the adhesion of the applied layers is generally not optimal.
DE 195 04 386 C2 discloses a method for producing a graduated coating of calcium phosphate phases and metal oxide phases on metal implants, preferably made of titanium.
In the electrochemical method using a substrate electrode formed by the metal implant and a counterelectrode, an aqueous solution with calcium and phosphate ions in the weakly acidic to neutral range is used as electrolyte and the substrate electrode formed by the implant is alternately polarized anodically and cathodically. Good growth of the bone onto the implant is achieved by the firm incorporation of calcium phosphate phases into the implant surface.
DE 100 29 520 Al describes a coating for a metal implant surface for improvement of the osteointegration. In an electrolysis cell the implant is cathodically polarized in an electrolyte containing calcium, phosphate and collagen. A mineralized collagen layer is formed on the surface of the implant by the method.
2 It is often only necessary for the implant to remain temporarily in the body, in particular in the case of cardiovascular and orthopedic implants. Implants made of a permanent material must then be removed by a further operation. For this reason, biocorrodable materials are used for implants. In this case biocorrosion is understood to be the gradual breakdown of the material caused by substances in the body. Even with biocorrodable materials an influence on the corrosion process is advantageous.
However, in the case of biocorrodable implants complete inhibition of the corrosion should not generally be achieved, since it is ultimately desirable for the implant to dissolve in the body after a certain time. Instead, it is merely necessary to influence the rate of corrosion, which enables a delayed degradation of the implant in the body as required.
One approach in order to improve the protection against corrosion is, as also in the case of permanent implants, the application of a corrosion-inhibiting layer.
By way of example reference is made to DE 103 57 281 Al, which discloses a degradable stent made of a magnesium material, which is provided with a coating which delays the degradation. In this connection the uncoated surface of the implant, which has a natural mixed oxide layer, is transformed into a mixed fluoride layer. The coating can be produced by dipping into fluoride-containing media with or without electrolytic assistance.
The object of the present invention is to provide an alternative method for the surface treatment of a biocorrodable implant, by which the rate of degradation of the implant can be adapted as required.
This object is achieved by the method according to the invention for the surface treatment of a biocorrodable implant according to claim 1.
The method according to the invention for the surface treatment of a biocorrodable implant by means of electrochemical reactions comprises the steps of:
a) providing an implant made of a bicorrodable magnesium alloy;
b) introducing the implant into an electrolyte with a pH value of pH 9 to pH 13;
c) electrochemically treating the surface of the implant,
3 wherein the implant serves as the working electrode and there is also a counterelectrode, and wherein the working electrode is alternately polarized cathodically and anodically, the current density being set to -0.1 to -75 mA/crn2 for the cathodic polarization and the current density is set to 0.1 to 25 mA/cm2 for the anodic polarization.
A magnesium hydride layer which grows from the implant surface into the implant is produced by the method according to the invention. Hydrogen ions are deposited cathodically from the electrolyte and are implanted into the surface of the implant.
A metal hydride layer is formed which, starting from the surface of the implant, virtually grows into the implant. Thus the method has the advantage that no change to the geometry of the implant takes place, since the metal hydride layer grows into the implant.
In the context of the present invention an implant should be understood to be an artificial material implanted in the body. Due to the use of a biocorrodable alloy for the implant body, the material used is gradually broken down by the substances in the body. It is provided that the implant consists, completely or in parts, of a biocorrodable alloy. The implants can fulfill different purposes and functions as required, such as for example interference screws, screws and plates for fixing bones, implants as medication depots, joint prostheses, stents, jaw and tooth implants. The list is merely by way of example and should in no way be understood as definitive.
The corrosion of the implant is slowed down by the hydride layer. The rate of corrosion of the hydride layer is less than that of the actual material without a hydride layer. So long as a closed hydride layer is present on the surface of the implant, the rate of corrosion of the implant is determined by the corrosion reaction of the magnesium hydride. As soon as this hydride layer is broken down by corrosion, the rate of corrosion of the implant corresponds to the rate of corrosion of the actual biocorrodable magnesium alloy.
Accordingly, after the hydride layer is broken down by corrosion the alloy is broken down further, as would be the case with an untreated implant. The formation of the hydride layer gives rise to a two-stage corrosion behavior.
The method according to the invention is preferably carried out as follows:
4 An implant, for example a compression screw, made of a biocorrodable metal alloy, preferably a biocorrodable magnesium alloy, is threaded onto a platinum wire.
Then the surface of the screw is activated by a bath in aqueous citric acid solution, preferably a 1-10%
solution, for 1 to 10 seconds. Then the testpiece is rinsed in deionized water, preferably for approximately 5 to 30 seconds.
For the further treatment the screw is fixed on a non-metallic object carrier.
The platinum wire is then pulled out. Indentations in the object carrier prevent later slipping of the screw.
Alternatively, the screw can be inserted through a plate with a hole, wherein the ends of the screw are free in order to produce the contact later, for example with terminals.
The screw is contacted with terminals in order to produce conductive contact.
For this purpose, the terminals are preferably attached to the external ends of the screw.
If very small implants such as very small screws or pins are used, no terminals are used, since contact cannot be produced by terminals. Instead a fine metal mesh is used, onto which the screws or pins are laid. The conductive contact to the implant is then produced with the aid of the mesh. The activation in the citric acid solution as well as the rinsing with water are likewise preferably carried out with the aid of the mesh.
Then the implant is introduced into the electrolyte. The electrolyte has a basic pH from pH 9 to pH 13, preferably from pH 9 to pH 10. Furthermore, it is preferable that the electrolyte contains 0.01 M NaOH and 0.2 M Na2SO4.
The formation of the magnesium hydride layer is made possible by the basic pH
value. At a pH value below pH 9 the magnesium material would corrode because of its base metal nature.
First of all, cleaning of the surface of the implant takes place by the action of positive pulses.
In this case the implant forms the working electrode. Furthermore, a counterelectrode is present in the arrangement. The counterelectrode preferably consists of a corrosion-resistant metal material, for example platinum, chromium-nickel steel, etc.
Glass vessels are preferably used as electrolysis cells.
=

For cleaning of the surface a positive pulse of 15 mA/cm2 to 35 mA/cm2 is preferable with a pulse length (pulse duration) of 0.10 seconds to 0.50 s and a total duration of the pulses of overall 5 min to 40 min. In this case particular preference is given to a positive pulse of 25 mA/cm2 at a pulse length of 0.20 s and a total duration of 20 min.
Then the hydrogenation of the implant takes place by negative and positive pulse changes alternating multiple times. For the method according to the invention it is preferable that the working electrode is alternately polarized cathodically and anodically multiple times, starting with a cathodic polarization and ending the deposition with a cathodic polarization.
In a preferred embodiment the current density is set to -35 to -55 mA/cm2 for the cathodic polarization and the current density is set to 5 to 25 mA/cm2 for the anodic polarization.
Furthermore, it is preferable that the current density and the total duration of the pulses are lower in an anodic polarization step than in a preceding anodic polarization step.
In the context of the present invention a polarization step should be understood as a succession of positive or negative pulses of a specific current density and pulse length.
Furthermore, it is preferable that the pulse length in the cathodic polarization is 0.40 s to 2.5 s and in the anodic polarization is 0.10 s to 0.50 s.
In a preferred embodiment of the method according to the invention the total duration of the pulses in a cathodic polarization step is 5 min to 90 min and the total duration of the pulses in an anodic polarization step is 1 min to 20 min.
In a further preferred embodiment the total duration of all pulses of the cathodic and anodic polarization steps is 20 min to 300 min, preferably 120 min to 240 min, particularly preferably 195 min.
In a preferred embodiment the method according to the invention consists of an alternating succession of five polarization steps:
1. Polarization step: cathodic polarization (negative pulse) Current density: - 0.1 to - 75 mA/cm2 Pulse length: 0.50 to 2.5 s Overall for 60 min (3.6 ks) 2. Polarization step: anodic polarization (positive pulse) Current density: + 0.1 to + 25 mA/cm2 Pulse length: 0.20 to 0.5 s Overall for 10 min (0.6 ks) 3. Polarization step: cathodic polarization (negative pulse) Current density: - 0.1 to - 75 mA/cm2 Pulse length: 0.50 to 2.5 s Overall for 60 min (3.6 ks) 4. Polarization step: anodic polarization (positive pulse) Current density: + 0.1 to + 15 mA/cm2 Pulse length: 0.20 to 0.5 s Overall for 5 min (0.3 ks)
5. Polarization step: cathodic polarization (negative pulse) Current density: - 0.1 to - 75 mA/cm2 Pulse length: 0.50 to 2.5 s Overall for 60 min (3.6 ks) A deposition rate of 5 to 8 nm/h is advantageously achieved by the method according to the invention.
In the context of the present invention the deposition rate should be understood to be the growth of the metal hydride layer from the surface of the implant into the implant.
After the alternating cathodic and anodic polarization, the implant is removed from the electrolyte and rinsed for approximately 30 to 60 seconds with deionized water. For passivation the implant is introduced into a hot air stream, preferably at a temperature of 60 C for 10 to 100 seconds. Until further use, the implant is preferably packaged in an airtight manner in order to prevent oxidation.
=

With the aid of the method according to the invention a magnesium hydride layer which increases the corrosion resistance of the implant is formed on the surface of the implant.
Higher current intensities than those specified for the method according to the invention can actually lead to a faster formation of the hydride layer within a defined time interval.
However, the faster growth of the hydride layer, which is accompanied by a different depth of penetration of the hydride layer, can lead to an inhomogeneous surface and thus to inconsistent corrosion. In the event of an inhomogeneous layer thickness of the formed magnesium hydride layer, thinner layer zones are completely broken down faster than thicker zones. If the magnesium hydride layer is already broken down on some zones, but not yet on others, this can lead to a dramatic increase in the rate of corrosion, since at these points there is no longer any hydride corrosion, but corrosion of the actual material takes place. Thus the implant is broken down inconsistently and can lose its stability.
The described parameters lead to an optimal surface in a reasonable time.
The growth of the hydride layer takes place during the cathodic polarization step. Longer or shorter pulse lengths only have an indirect effect on the growth of the hydride layer. In addition to the electrochemical reaction the pulse primarily serves the purpose that the formed hydrogen (H2) is released uniformly and in short intervals on the working electrode.
Accumulations of hydrogen bubbles can lead to slowing down or interruption of the buildup of the hydride layer at this point, since in the extreme case contact no longer takes place between the material (working electrode) and the electrolyte.
Within a polarization step there is a short resting phase ("break") between the individual pulses. In this case this resting phase between 'current is applied' and 'current is not applied' should preferably be long enough so that the hydrogen bubbles can rise up from the working electrode.
In particular square wave pulse currents are advantageous for the method according to the invention, since they provide enough time so that the hydrogen can rise up. In the context of the present invention a square wave pulse current is a current with a steep rise and fall and a constant plateau located between them. The same applies to the pulse length.
With many short pulses in a time interval, the resting phase is too short and a substantial accumulation df hydrogen gas in the form of bubbles occurs on the working electrode.

In an advantageous configuration of the method according to the invention a rest break of at least 0.1 s is provided between two pulses.
In this case the geometry of the implant (working electrode) also has an effect on the optimal p.ulse length. A smooth or uniform surface encourages the hydrogen bubble to drop off. The pulse length can be truncated here. Samples with an uneven surface or thread, as in the case of helical implants, or a supporting mesh as electrode, as used in the case of small implants, leads to the hydrogen bubbles requiring more time to drop off.
Thus the pulse length is adjustable according to the geometry of the implant.
If too many hydrogen bubbles accumulate on the working electrode, the pulse length is made longer.
In this way the individual method parameters are adaptable to different implant sizes and geometries. Moreover, the rate of degradation of the implant can be adapted as required. If a fast degradation is desirable, the total duration of the pulses, that is to say the duration of the respective cathodic polarization step, is reduced in order to limit the formation of the hydride layer to a small depth of penetration and thus to a small layer thickness. On the other hand, in the event of a longer total duration of the pulses the depth of penetration and thus the layer thickness is increased.
In a further embodiment of the method according to the invention it is preferable that the implant provided is made of a biocorrodable magnesium alloy which has a magnesium component of at least 50%. The following composition is particularly preferred: a rare earth metal component of 2.5 to 5 % by weight, an yttrium component of 1.5 to 5 % by weight, a zirconium component of 0.1 to 2.5 % by weight, a zinc component of 0.01 to 0.8 % by weight, as well as unavoidable impurities, wherein the total content of possible contaminants is below 1 % by weight and the aluminum component is less than 0.5 % by weight, preferably less than 0.1 % by weight and the rest up to 100 % by weight is magnesium.
Furthermore, it is preferable that the implant consists completely or in parts of a biocorrodable magnesium alloy.

= 9 Further advantages are provided by an implant with a corrosion-inhibiting coating, which is or may be obtained by the method according to the invention.
After the method according to the invention has been carried out, the surface of the implant has a hydrogenated outer layer which increases the corrosion resistance. In this case it is preferable that the corrosion-inhibiting hydride layer has a layer thickness of at least 10 nm, preferably at least 15 nm, particularly preferably 20 nm.
In a further preferred embodiment the implant provided, which is made of a biocorrodable magnesium alloy, has a magnesium component of at least 50%. The biocorrodable magnesium alloy from which the implant is manufactured has the following composition: a rare earth metal component of 2.5 to 5 % by weight, an yttrium component of 1.5 to 5 % by weight, a zirconium component of 0.1 to 2.5 % by weight, a zinc component of 0.01 to 0.8 % by weight, as well as unavoidable impurities, wherein the total content of possible contaminants is below 1 % by weight and the aluminum component is less than 0.5 % by weight, preferably less than 0.1 % by weight and the rest up to 100 % by weight is magnesium.
Due to the low, almost negligible content of aluminum the biocorrodable magnesium alloy is suitable for the use of implants in human medicine, since aluminum is alleged to have properties which are harmful to health, such as the promotion of Alzheimer's disease or cancer.
Furthermore, it is preferable that the implant consists completely or in parts of a biocorrodable magnesium alloy.
The method according to the invention is explained in greater detail with reference to an embodiment.
Embodiment A round material made of the magnesium alloy ZfW 102 PM F is treated by the method according to the invention.

In this case the magnesium alloy ZfW 102 PM F consists of a rare earth metal component (including neodymium) of 4.05 % by weight, the neodymium component corresponding to 2.35 % by weight, an yttrium component of 1.56 % by weight, a zirconium component of 0.78 % by weight, a zinc component of 0.4 % by weight, an aluminum component of 0.0032 % by weight. The rest up to 100 % by weight is magnesium.
The round material is a full cylinder with a diameter of 6 mm and a length of 3 cm. This full cylinder functions as a working electrode. A platinum electrode with a titanium core having a diameter of 6 mm and a length of 7 cm is used as the counterelectrode.
A 500 ml beaker is used as electrolysis cell. The electrolyte consists of 0.01 M NaOH and 0.2 M Na2SO4and has a pH value of 9.4. The method is carried out at 24 C.
For cleaning of the surface a positive pulse of 25 mA/cm2 at a pulse length of 0.20 s and a total duration of 20 min is used.
Then the hydrogenation of the round piece takes place by alternating negative and positive pulse changes. The method according to the invention is carried out in an alternating succession of five polarization steps:
1. Polarization step: cathodic polarization (negative pulse) Current density: -50 mA/cm23 Pulse length: 0.50 s Overall for 60 min (3.6 ks) a Polarization step: anodic polarization (positive pulse) Current density: +20 mA/cm2 Pulse length: 0.20 s Overall for 10 min (0.6 ks) 3. Polarization step: cathodic polarization (negative pulse) Current density: -50 mA/cm2 Pulse length: 0.50 s Overall for 60 min (3.6 ks) 4. Polarization step: anodic polarization (positive pulse) Current density: + 10 mA/cm2 Pulse length: 0.20 s Overall for 5 min (0.3 ks) 5. Polarization step: cathodic polarization (negative pulse) Current density: -50 mA/cm2 Pulse length: 0.50 s Overall for 60 min (3.6 ks) After a total of 195 min a layer thickness of 18 nm is achieved.
The success of the treatment is determined by means of X-ray diffractometry (RDA), secondary ion mass spectrometry (SIMS) as well as determination of the free corrosion potential. An identical round material made of the magnesium alloy ZfW 102 PM
F which has not been treated by the method according to the invention serves as a comparison.
The results are presented in Figures 1 to Figure 4.
Figure 1 shows the hydride detection by means of X-ray diffractometry (XRD).
Figure 2 shows the hydride detection by means of secondary ion mass spectrometry (SIMS).
Figure 3 shows the determination of the free corrosion potential.
Figure 4 shows the corrosion rate in a Ringer's lactate solution.
A round piece which had been treated by the method according to the invention according to exemplary embodiment 1 was examined by means of X-ray diffractometry. The phases present in the material are illustrated in Figure 1. The occurrence of magnesium hydride phases (MgH2) is evidence of the hydride layer formed by the method according to the invention.
Moreover, a round piece which had been treated by the method according to the invention according to exemplary embodiment 1 was examined by means of SIMS. Figure 2 shows =
the hydride detection as a function of the depth of penetration of the hydrogen ions into the workpiece.
Moreover, the free corrosion potential of a round piece which had been treated by the method according to the invention according to exemplary embodiment 1 as well as an untreated round piece is determined. Figure 3 shows that at 1680 mV the treated round piece (H-EIR, H electrochemical induced reaction) has a more positive corrosion potential than the untreated round piece.
Figure 4 shows the corrosion rate of an untreated round piece and a round piece which had been treated by the method according to the invention according to exemplary embodiment 1. The corrosion rate was determined under conditions similar to those in the human body in each case at 37 C in a Ringer's lactate solution (125-134 mmo1/1 Na, 4.0-5.4 mmo1/1 K+, 0.9-2.0 mmo1/1 Ca2, 106-117 mmol/ICI-, 25-31 [mmo1/1] lactate). A Ringer's solution has a composition comparable to that of the blood plasma and the extracellular liquid. It can be seen that the treated round piece has a lower corrosion rate than the untreated round piece.
Thus for example the untreated round piece has a corrosion rate of 0.415 mm/year after 432 h and a corrosion rate of 0.339 mm/year after 624 h, and on the other hand the round piece treated by the method according to the invention according to exemplary embodiment 1 has e corrosion rate of 0.224 mm/year after 432 h and a corrosion rate of 0.153 mm/year after 624 h (cf. Figure 4).
Thus because of the slower rate of degradation, after implantation into the human body a biocorrodable implant which is treated by the method according to the invention has a longer service life than an untreated implant of the same structural design. Thus with the aid of the method according to the invention the rate of degradation can be adapted to the particular purpose and to the necessary residence time of the implant in the body. If it is necessary to have a longer residence time in the body than the actual material permits, the corrosion resistance can be increased by the treatment of an implant by the method according to the invention. Moreover, the increased corrosion resistance gives the implant an increased stability, since corrosion is accompanied by a loss of mass of the implant. If the implant breaks down too quickly in the body, in some circumstances the bone does not have sufficient time to grow into the implant and to replace the material by bone material. Thus the choice of the corrosion resistance is dependent upon the position of the implant in the body or also dependent upon the patient. Thus in the case of older people, who exhibit slower bone growth, a biocorrodable implant with a substantially slower rate of degradation can be used. On the other hand, if only a small implant into the bone is used, which is not subject to substantial mechanical stresses, an implant with a smaller hydride layer thickness can be used.

Claims (10)

Claims
1. A method for the surface treatment of a biocorrodable implant by means of electrochemical reactions comprising the steps of:
a) providing an implant made of a bicorrodable magnesium alloy;
b) introducing the implant into an electrolyte with a pH value of pH 9 to pH 13;
c) electrochemically treating the surface of the implant, wherein the implant serves as the working electrode and there is also a counterelectrode, and wherein the working electrode is alternately polarized cathodically and anodically, the current density being set to -0.1 to -75 mA/cm2 for the cathodic polarization and the current density is set to 0.1 to 25 mA/cm2 for the anodic polarization.
2. The method according to claim 1, characterized in that the working electrode is alternately polarized cathodically and anodically multiple times, starting with a cathodic polarization and ending the deposition with a cathodic polarization.
3 The method according to claims 1 or 2, characterized in that the current density and the total duration of the pulses are lower in an anodic polarization step than in a preceding anodic polarization step.
4. The method according to one of the preceding claims, characterized in that the pulse length in the cathodic polarization is 0.40 s to 2.5 s and in the anodic polarization is 0.10 s to 0.50 s.
5. The method according to one of the preceding claims, characterized in that the total duration of the pulses in a cathodic polarization step is 5 min to 90 min and the total duration of the pulses in an anodic polarization step is 1 min to 20 min.
6 The method according to one of the preceding claims, characterized in that the total duration of all pulses is 20 min to 300 min.
7. The method according to one of the preceding claims, characterized in that a hydride layer of at least 10 nm, preferably at least 15 nm is achieved on the surface of the implant.
8. An implant obtained by the method according to one of claims 1 to 7 and having a corrosion-inhibiting coating.
9 The implant according to claim 8, wherein the corrosion-inhibiting hydride layer has a layer thickness of at least 10 nm, preferably at least 15 nm.
10. The implant according to claims 8 or 9, characterized in that the biocorrodable magnesium alloy contains a rare earth metal component of 2.5 to 5 % by weight, an yttrium component of 1.5 to 5 % by weight, a zirconium component of 0.1 to 2.5 % by weight, a zinc component of 0.01 to 0 8 % by weight, as well as unavoidable impurities, wherein the total content of possible contaminants is below 1 % by weight and the aluminum component is less than 0.5 % by weight, and the rest up to 100 % by weight is magnesium.
CA2946676A 2014-04-23 2015-05-21 Method for the surface treatment of a biocorrodable implant Abandoned CA2946676A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE201410105732 DE102014105732B3 (en) 2014-04-23 2014-04-23 Process for the surface treatment of a biocorrodible implant and implant obtained by the process
PCT/EP2015/061210 WO2015162306A1 (en) 2014-04-23 2015-05-21 Method for the surface treatment of a biocorrodable implant

Publications (1)

Publication Number Publication Date
CA2946676A1 true CA2946676A1 (en) 2015-10-29

Family

ID=52693491

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2946676A Abandoned CA2946676A1 (en) 2014-04-23 2015-05-21 Method for the surface treatment of a biocorrodable implant

Country Status (12)

Country Link
EP (1) EP3134563A1 (en)
JP (1) JP2017519538A (en)
KR (1) KR20170023799A (en)
CN (1) CN106456839A (en)
AU (1) AU2015250774A1 (en)
BR (1) BR112016024664A2 (en)
CA (1) CA2946676A1 (en)
DE (1) DE102014105732B3 (en)
IL (1) IL248450A0 (en)
RU (1) RU2016144709A (en)
SG (1) SG11201608850RA (en)
WO (1) WO2015162306A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016119234A1 (en) * 2016-10-10 2018-04-12 Syntellix Ag Screw drive with integrated torque lock
CN108553187A (en) * 2018-05-16 2018-09-21 广州市健齿生物科技有限公司 A kind of porous dental implant and manufacturing method of internal combination biodegradable magnesium alloy
CN114571015B (en) * 2022-03-17 2023-08-11 江苏江航智飞机发动机部件研究院有限公司 Precise electrolytic machining method for titanium-aluminum alloy spinal cord fixing nail

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19504386C2 (en) * 1995-02-10 1997-08-28 Univ Dresden Tech Process for the production of a graded coating from calcium phosphate phases and metal oxide phases on metallic implants
DE10029520A1 (en) * 2000-06-21 2002-01-17 Merck Patent Gmbh Coating for metallic implant materials
DE10357281A1 (en) * 2003-12-05 2005-07-14 Hassel, Thomas, Dipl.-Ing. Degradable stent for blood vessel support made of magnesium material, comprises degradation-inhibiting biocompatible coating
US20080097577A1 (en) * 2006-10-20 2008-04-24 Boston Scientific Scimed, Inc. Medical device hydrogen surface treatment by electrochemical reduction
CN100998893B (en) * 2006-12-26 2010-05-12 重庆大学 Biodegradable rare earth magnesium alloy material
DE102008054920A1 (en) * 2008-12-18 2010-07-01 Biotronik Vi Patent Ag Implant and method for producing a layer structure
DE102010027532B8 (en) * 2010-07-16 2014-09-18 Aap Biomaterials Gmbh Process for PEO coating
ES2558564T3 (en) * 2011-08-15 2016-02-05 Meko Laserstrahl-Materialbearbeitungen E.K. Magnesium alloy, as well as endovascular prostheses that contain this

Also Published As

Publication number Publication date
BR112016024664A2 (en) 2018-06-19
JP2017519538A (en) 2017-07-20
CN106456839A (en) 2017-02-22
AU2015250774A1 (en) 2016-12-01
DE102014105732B3 (en) 2015-04-09
WO2015162306A8 (en) 2015-12-17
SG11201608850RA (en) 2016-12-29
EP3134563A1 (en) 2017-03-01
WO2015162306A1 (en) 2015-10-29
RU2016144709A (en) 2018-05-23
IL248450A0 (en) 2016-11-30
KR20170023799A (en) 2017-03-06

Similar Documents

Publication Publication Date Title
Jin et al. Corrosion resistance and cytocompatibility of tantalum-surface-functionalized biomedical ZK60 Mg alloy
Jamesh et al. Effects of zirconium and oxygen plasma ion implantation on the corrosion behavior of ZK60 Mg alloy in simulated body fluids
Ascencio et al. An investigation of the corrosion mechanisms of WE43 Mg alloy in a modified simulated body fluid solution: the effect of electrolyte renewal
Mohedano et al. Metal release from ceramic coatings for dental implants
US20100131052A1 (en) Method for producing a corrosion-inhibiting coating on an implant made of a biocorrodible magnesium alloy and implant produced according to the method
Gopi et al. A comparative study on the direct and pulsed current electrodeposition of hydroxyapatite coatings on surgical grade stainless steel
KR100714244B1 (en) Osseoinductive metal implants for a living body and producing method thereof
Kannan Electrochemical deposition of calcium phosphates on magnesium and its alloys for improved biodegradation performance: A review
ES2385770T3 (en) Method to form a bioactive coating
JPWO2007108450A1 (en) Degradation time control method for medical biodegradable device
Gnedenkov et al. Hydroxyapatite-containing PEO-coating design for biodegradable Mg-0.8 Ca alloy: Formation and corrosion behaviour
CA2571853A1 (en) Bioceramic coated apparatus and method of forming the same
EP1364079B1 (en) A process for electrochemical deposition of tantalum
Kannan Hydroxyapatite coating on biodegradable magnesium and magnesium-based alloys
Rončević et al. Electrodeposition of hydroxyapatite coating on AZ91D alloy for biodegradable implant application
US20110171600A1 (en) Bio-Implant Having a Screw Body with Nanoporous Spiral Groove and the Method of Making the Same
Gugelmin et al. Electrochemical stability and bioactivity evaluation of Ti6Al4V surface coated with thin oxide by EIS for biomedical applications
CA2946676A1 (en) Method for the surface treatment of a biocorrodable implant
Shangguan et al. Comparison study of different coatings on degradation performance and cell response of Mg-Sr alloy
Huan et al. Effect of aging treatment on the in vitro nickel release from porous oxide layers on NiTi
EP2663671A2 (en) Metal treatment
Lu et al. Enhanced corrosion resistance of TA2 titanium via anodic oxidation in mixed acid system
Mousa et al. Surface modification of magnesium and its alloys using anodization for orthopedic implant application
Farina et al. Effect of surface modification on the corrosion resistance of Zr-2.5 Nb as material for permanent implants
JP2011072617A (en) Implantation material and method of manufacturing the same

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180131